N-Act AI

N-Act AI is biostate.AI's next-generation multi-omics intelligence model designed to transform omics data into precise, scalable, and clinically actionable insights. Developed as one of two flagship technologies from biostate.AI, N-Act is built for researchers, clinicians, and life sciences organizations seeking to track disease progression, predict future outcomes, and enable earlier intervention across patient populations.

N-Act AI integrates molecular data spanning DNA, RNA, and proteins to uncover hidden disease mechanisms and deliver patient-specific predictive intelligence. A demonstrated application includes guiding bone marrow transplant decisions for AML patients, illustrating the platform's capacity to support high-stakes clinical workflows.

Core Capabilities

• AI-driven Discovery: Detects molecular signatures across DNA, RNA, and proteins to reveal hidden disease mechanisms that may not be apparent through conventional analysis.
• Predictive Modeling: Learns patient-specific patterns to forecast individual disease risks and treatment responses, enabling more personalized clinical decision-making.
• Explainable Insights: Generates interpretable models that make biological decisions transparent and reproducible, supporting scientific rigor and regulatory accountability.

Platform Vision and Broader AI Portfolio

• N-Act AI is part of biostate.AI's broader mission to lift healthspans for everyone by transforming omics data into intelligence.
• It operates alongside K-Dense, biostate.AI's autonomous multi-agent scientific platform, together enabling end-to-end discovery from hypothesis generation through to clinically actionable outputs.
• The combined platform is designed to track disease progression, predict future biological states, and support earlier intervention strategies.

Visualization and Interpretability

• N-Act AI includes AI visualization capabilities, allowing users to explore and interact with the model's outputs in an interpretable format.
• The emphasis on explainability ensures that biological decisions derived from multi-omics data remain transparent and reproducible for scientific and clinical stakeholders.

biostate.AI is headquartered in Houston, TX, and can be reached at [email protected]. The platform reflects a commitment to advancing biomedical AI for real-world clinical and research applications, with collaborations spanning leading academic and industry partners.